Company Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-23 pm EST			5-day change	1st Jan Change
2.390 ^USD	+1.70%		+4.82%	+48.45%

Jan. 13	Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024	CI
Jan. 13	Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	CI

Business description: Neuronetics, Inc.

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Number of employees: 201

Sales by Activity: Neuronetics, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
Surgical & Medical Equipment	62.66M	49.24M	55.31M	65.21M	71.35M

See all business segments

Geographical breakdown of sales: Neuronetics, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
United States	60.76M	47.52M	53.45M	63.41M	69.34M
International	1.9M	1.72M	1.86M	1.8M	2.01M

See all geographic segments

Managers: Neuronetics, Inc.

Director	Title	Age	Since
Keith Sullivan CEO	Chief Executive Officer	66	2020-07-13
Stephen Furlong DFI	Director of Finance/CFO	61	2019-07-21
Cory Anderson CTO	Chief Tech/Sci/R&D Officer	-	2021-02-28
W. Macan CMP	Compliance Officer	52	2020-01-20
Lisa Metzner-Rosas SAM	Sales & Marketing	-	2023-04-30

See NEURONETICS, INC. governance

Members of the board: Neuronetics, Inc.

Manager	Title	Age	Since
Glenn Muir BRD	Director/Board Member	66	2017-06-30
Sheryl Conley BRD	Director/Board Member	64	2019-09-30
Keith Sullivan BRD	Director/Board Member	66	2020-07-13
Robert Cascella CHM	Chairman	70	2021-05-26
Megan Rosengarten BRD	Director/Board Member	48	2021-08-01
Sasha Cucuz BRD	Director/Board Member	48	2024-12-09
Avinash Amin BRD	Director/Board Member	55	2024-12-09

Composition of the Board of Directors

Shareholders: Neuronetics, Inc.

Name	Equities	%	Valuation
Madryn Asset Management LP 43.55 %	24,237,061	43.55 %	39 M $
Kent Lake PR LLC 3.734 %	2,077,848	3.734 %	3 M $
Sasha Cucuz 3.424 %	1,905,626	3.424 %	3 M $
Cannell Capital LLC 2.362 %	1,314,266	2.362 %	2 M $
Vanguard Global Advisers LLC 2.336 %	1,299,915	2.336 %	2 M $

List of NEURONETICS, INC. shareholders

Company details: Neuronetics, Inc.

Neuronetics, Inc.

3222 Phoenixville Pike

19355, Malvern

+610 640 4202

http://www.neurostar.com

Other Advanced Medical Equipment & Technology

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
NEURONETICS, INC.	+1.70%	+4.82%	-28.66%	-32.87%	72.53M
THERMO FISHER SCIENTIFIC INC.	+0.05%	+2.34%	+4.38%	-0.94%	220B
INTUITIVE SURGICAL, INC.	-0.29%	+4.21%	+63.88%	+125.82%	217B
DANAHER CORPORATION	+0.61%	+1.55%	+5.84%	-12.41%	177B
BOSTON SCIENTIFIC CORPORATION	+1.33%	+3.53%	+67.67%	+136.54%	150B
SIEMENS HEALTHINEERS AG	+0.70%	+6.55%	+6.42%	-10.54%	63.32B
AGILENT TECHNOLOGIES, INC.	-0.10%	+5.34%	+15.81%	+10.86%	43.54B
EDWARDS LIFESCIENCES CORPORATION	-0.16%	-1.33%	-7.88%	-38.81%	40.65B
GE HEALTHCARE TECHNOLOGIES INC.	+0.95%	+3.72%	+19.67%	-	40.28B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.73%	-0.52%	-15.31%	-31.82%	38.72B
Average	+0.48%	+2.65%	+13.18%	+16.20%	99.05B
Weighted average by Cap.	+0.02%	+2.99%	+27.21%	+44.53%